Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 21Lung Neoplasms 18Mesothelioma, Malignant 5Adenocarcinoma, Bronchiolo-Alveolar 4Adenocarcinoma of Lung 4Solitary Fibrous Tumor, Pleural 3NSCLC 2Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Neoplasm, Residual 1Mesothelioma 1Head and Neck Neoplasms 1

Interventions

Pemetrexed 14Carboplatin 13osimertinib 11aflutinib 9Drug Therapy 9Gefitinib 8Radiotherapy 6Docetaxel 6Cisplatin 6pembrolizumab 5anlotinib 5Radiosurgery 5Paclitaxel 5icotinib 4Vinorelbine 4Gemcitabine 4Erlotinib Hydrochloride 4tislelizumab 3camrelizumab 3apatinib 3HM781-36B 3toripalimab 2spartalizumab 2rezivertinib 2dacomitinib 2Tyrosine Kinase Inhibitors 2Thalidomide 2Surgical Procedures, Operative 2S 1 (combination) 2Platinum 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NSCLC × Chemotherapy, Adjuvant × Thoracic × Clear all
NCT07089199 2025-07-28

TitAN

Qilu Hospital of Shandong University

Phase 2 Not yet recruiting
34 enrolled
Thoracic

NSCLC

NCT05286957 2023-03-17

Seagull

The First Affiliated Hospital of Zhengzhou University

Phase 2 Recruiting
60 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡